Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
Saved in:
| Title: | Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. |
|---|---|
| Authors: | van Schooten J; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands., van Haaren MM; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands., Li H; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., McCoy LE; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Division of Infection and Immunity, University College London, London, United Kingdom., Havenar-Daughton C; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America., Cottrell CA; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America., Burger JA; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands., van der Woude P; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands., Helgers LC; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands., Tomris I; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands., Labranche CC; Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, North Carolina, United States of America., Montefiori DC; Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, North Carolina, United States of America., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative-Neutralizing Antibody Center (IAVI-NAC), The Scripps Research Institute, La Jolla, California, United States of America.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative-Neutralizing Antibody Center (IAVI-NAC), The Scripps Research Institute, La Jolla, California, United States of America.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America., Moore JP; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America., Sanders RW; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America., Crotty S; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America., Shaw GM; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America., van Gils MJ; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands. |
| Source: | PLoS pathogens [PLoS Pathog] 2021 Aug 25; Vol. 17 (8), pp. e1009736. Date of Electronic Publication: 2021 Aug 25 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34432859 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22van+Schooten+J%22">van Schooten J</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Haaren+MM%22">van Haaren MM</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.<br /><searchLink fieldCode="AU" term="%22McCoy+LE%22">McCoy LE</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; Division of Infection and Immunity, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Havenar-Daughton+C%22">Havenar-Daughton C</searchLink>; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Cottrell+CA%22">Cottrell CA</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Burger+JA%22">Burger JA</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Woude+P%22">van der Woude P</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Helgers+LC%22">Helgers LC</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tomris+I%22">Tomris I</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Labranche+CC%22">Labranche CC</searchLink>; Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Montefiori+DC%22">Montefiori DC</searchLink>; Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Ward+AB%22">Ward AB</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative-Neutralizing Antibody Center (IAVI-NAC), The Scripps Research Institute, La Jolla, California, United States of America.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Burton+DR%22">Burton DR</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, United States of America.; International AIDS Vaccine Initiative-Neutralizing Antibody Center (IAVI-NAC), The Scripps Research Institute, La Jolla, California, United States of America.; Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, California, United States of America.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Moore+JP%22">Moore JP</searchLink>; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Sanders+RW%22">Sanders RW</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.<br /><searchLink fieldCode="AU" term="%22Crotty+S%22">Crotty S</searchLink>; Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.<br /><searchLink fieldCode="AU" term="%22Shaw+GM%22">Shaw GM</searchLink>; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.<br /><searchLink fieldCode="AU" term="%22van+Gils+MJ%22">van Gils MJ</searchLink>; Department of Medical Microbiology, Amsterdam Infection & Immunity Institute, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2021 Aug 25; Vol. 17 (8), pp. e1009736. <i>Date of Electronic Publication: </i>2021 Aug 25 (<i>Print Publication: </i>2021). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34432859 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.ppat.1009736 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1009736 Titles: – TitleFull: Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: van Schooten J – PersonEntity: Name: NameFull: van Haaren MM – PersonEntity: Name: NameFull: Li H – PersonEntity: Name: NameFull: McCoy LE – PersonEntity: Name: NameFull: Havenar-Daughton C – PersonEntity: Name: NameFull: Cottrell CA – PersonEntity: Name: NameFull: Burger JA – PersonEntity: Name: NameFull: van der Woude P – PersonEntity: Name: NameFull: Helgers LC – PersonEntity: Name: NameFull: Tomris I – PersonEntity: Name: NameFull: Labranche CC – PersonEntity: Name: NameFull: Montefiori DC – PersonEntity: Name: NameFull: Ward AB – PersonEntity: Name: NameFull: Burton DR – PersonEntity: Name: NameFull: Moore JP – PersonEntity: Name: NameFull: Sanders RW – PersonEntity: Name: NameFull: Crotty S – PersonEntity: Name: NameFull: Shaw GM – PersonEntity: Name: NameFull: van Gils MJ IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 08 Text: 2021 Aug 25 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1553-7374 Numbering: – Type: volume Value: 17 – Type: issue Value: 8 Titles: – TitleFull: PLoS pathogens Type: main |
| ResultId | 1 |